|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 31, 2020 07:07PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 31, 2020 07:28PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 31, 2020 08:00PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
3
|
Resverlogix Corp.
|
Jul 15, 2019 11:02AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
7
|
Resverlogix Corp.
|
Jul 15, 2019 02:12PM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
5
|
Resverlogix Corp.
|
Sep 30, 2019 10:25AM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
3
|
Resverlogix Corp.
|
Sep 30, 2019 11:09AM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 06:29PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
5
|
Resverlogix Corp.
|
Nov 25, 2019 06:46PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 07:11PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 08:02PM
|
|
Re: Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 08:40AM
|
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
3
|
Resverlogix Corp.
|
May 11, 2019 07:00PM
|
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 10:03AM
|
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 10:13AM
|
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 10:16AM
|
|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 10:28AM
|
|
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
|
5
|
Resverlogix Corp.
|
Dec 02, 2019 09:02AM
|
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
3
|
Resverlogix Corp.
|
Jul 08, 2019 09:31AM
|
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
4
|
Resverlogix Corp.
|
Jan 14, 2019 07:43PM
|
